Table 1.
Patient characteristics
| Baseline characteristics (n = 1497) | Median (IQR) | |
|---|---|---|
| Age (at operation) | 62 (8.79) | |
| 6.3 (3.8) | ||
| Preoperative PSA | <10 (%) | 1240 (82.8) |
| 10–20 (%) | 197 (13.2) | |
| >20 (%) | 60 (4) | |
| Clinical T-stage | 1 (%) | 1009 (67.4) |
| 2 (%) | 448 (29.9) | |
| 3 (%) | 37 (2.5) | |
|
| ||
| RP pathology characteristics (n = 1497) | ||
|
| ||
| Gleason score | ≤6 | 191 (12.8) |
| =7 | 1164 (77.8) | |
| ≥8 | 142 (9.5) | |
| pT-stage | T2 | 1042 (69.7) |
| T3 | 454 (30.3) | |
| Perineural invasion (%) | 1173 (78.4) | |
| Extraprostatic extension (%) | 448 (29.9) | |
| Seminal vesicle invasion (%) | 92 (6.1) | |
| Positive surgical margin (%) | 390 (26.1) | |
| Cancer volume (cc), Median (IQR) | 2.1 (3.2) | |
|
| ||
| Follow-up (n = 1159) | ||
|
| ||
| PSA recurrence | 238 (20.5) | |
| Median (IQR) time to recurrence (months) | 8 (22) | |
| Median (IQR) follow up (months) | Overall | 14 (24) |
| No recurrence | 15 (24) | |
PSA: prostate-specific antigen; RP: radical prostatectomy; IQR: interquartile range.